Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Prof. Tatsuya Yamasoba | Otolaryngology | Best Researcher Award

Prof. Tatsuya Yamasoba | Otolaryngology | Best Researcher Award

Tokyo Teishin Hospital, Japan.

Prof. Tatsuya Yamasoba is a distinguished otologist and researcher specializing in hearing loss and otolaryngology. He currently serves as the Director of Tokyo Teishin Hospital and is Professor Emeritus at the University of Tokyo. With an extensive career in academia and clinical practice, he has made groundbreaking contributions to understanding and treating hearing loss. He previously chaired the Department of Otolaryngology at the University of Tokyo (2007–2023) and served as Vice Dean of the Faculty of Medicine (2017–2023). He is actively involved in international otology organizations and currently leads the Japanese Audiological Society.

Profile

Google Scholar

🎓 Education

Prof. Tatsuya Yamasoba earned his Doctor of Medicine (M.D.) from the University of Tokyo in 1983, where he laid the foundation for his distinguished career in otology and hearing research. To further expand his expertise, he pursued a research fellowship at the Kresge Hearing Research Institute, University of Michigan (1996–1998). During this time, he conducted advanced studies on the pathophysiology of hearing loss, focusing on noise-induced and age-related auditory dysfunctions. His time at Michigan provided him with valuable insights into the molecular mechanisms of hearing loss, shaping his future contributions to otolaryngology and auditory neuroscience.

💼 Experience

Prof. Tatsuya Yamasoba is a highly esteemed leader in the field of otolaryngology, currently serving as the Director of Tokyo Teishin Hospital (2023–Present). He is also Professor Emeritus at the University of Tokyo, where he has made significant contributions to medical education and research. From 2017 to 2023, he held the position of Vice Dean of the Faculty of Medicine at the University of Tokyo, overseeing academic and clinical advancements.

Previously, he led the Department of Otolaryngology at the University of Tokyo (2007–2023), where he played a pivotal role in advancing hearing research and surgical innovations. His influence extends globally as an Executive Board Member of the International Federation of ORL Societies, Asia Oceania ORL-HNS, and ORL Society of Japan. Additionally, he currently serves as the President of the Japanese Audiological Society, driving forward research and clinical developments in audiology and hearing disorders.

🔬 Research Interests

Prof. Yamasoba's research focuses on the pathophysiology of hearing loss, particularly noise-induced hearing loss, age-related hearing loss, and vestibular dysfunction caused by mitochondrial DNA mutations. His work has identified oxidative stress and mitochondrial dysfunction as key factors in hearing disorders, leading to novel strategies for prevention and treatment. His current projects include:

Nanomicell-based Hair Cell Regeneration (Atoh1 mRNA & p27 siRNA therapy)

iPS Cell-Induced Regenerative Medicine for Sensory Organs

Nanomicellization of Chemotherapeutic Agents to Reduce Ototoxicity

🏆 Awards & Recognitions

Young Investigator Award, Japan Otological Society

Distinguished Researcher Award, Japanese Society of Otorhinolaryngology

Honorary President (2027), Asia Oceania ORL-HNS Congress

Collegium ORLAS President (2023)

📚 Selected Publications

1️⃣ Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging
📄 Science (2005) | Cited by: 2,541

2️⃣ Novel Scoring System and Algorithm for Classifying Chronic Rhinosinusitis: The JESREC Study
📄 Allergy (2015) | Cited by: 675

3️⃣ Current Concepts in Age-Related Hearing Loss: Epidemiology and Mechanistic Pathways
📄 Hearing Research (2013) | Cited by: 674

4️⃣ Mechanisms of Noise-Induced Hearing Loss Indicate Multiple Methods of Prevention
📄 Hearing Research (2007) | Cited by: 528

5️⃣ Rational Design of Reversible Fluorescent Probes for Live-Cell Imaging and Quantification of Fast Glutathione Dynamics
📄 Journal (TBD)

Dr. Jad El Masri | Medical Research | Young Scientist Award

Dr. Jad El Masri | Medical Research | Young Scientist Award

American University of Beirut, Lebanon.

Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.

Profile

Google Scholar

🎓 Education

Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).

💼 Experience

Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.

🔬 Research Interests

Oncology – Brain cancer, genetic biomarkers, metastasis

Epidemiology – Risk factors, diet effects, environmental exposure

Neurosurgery – Computational biology, single-cell DNA sequencing

🏆 Awards & Recognitions

Young Scientist Award – Recognized for contributions to neuroscience research

Editorial Board Member – Journal of Public Health Research

Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons

📚 Selected Publications

1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34

2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27

3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23

4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22

5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22

 

 

 

 

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Institute of Telecommunications, Portugal.

Ana Filipa Soares Pires is a Junior Researcher specializing in biomaterials and bioelectronic devices at Instituto de Telecomunicações, Instituto Superior Técnico. Her research focuses on creating systems that respond to stimuli like light, electricity, and magnetism to guide cell behavior for tissue regeneration. She is particularly interested in drug delivery systems, such as liposomes, nanoparticles, and hydrogels, and has made groundbreaking contributions to bioelectronics and personalized medicine. Ana's work on biodegradable LEDs for real-time monitoring of anticancer drugs has propelled innovations in precision medicine and tissue engineering.

Profile

Scopus

Orcid

Education 🎓

Ana Filipa Soares Pires holds a Ph.D. in Radiation Biology and Biophysics, where she specialized in biomaterials and bioelectronics. Her educational background also includes Master's Fellowships in Pharmacokinetic Analysis (PEstOE/EEI/LA0008/2014), focusing on the pharmacokinetics of nanostructured films, and in Textile Electrode Design (2014), where she innovated designs using cotton and silk electrodes to collect electrical signals from living tissue. Her education laid the foundation for her pioneering work in bioelectronics, tissue engineering, and drug delivery systems.

Experience  💼

Ana's research experience spans multiple interdisciplinary projects, including the development of drug delivery systems, tissue scaffolds, and biosensors. She has collaborated with leading researchers from institutions such as IFSCAR (Brazil) and Synchrotron Facilities (Denmark), and her work is published in prestigious journals like European Polymer Journal and Fungal Biology. As a guest editor, Ana has also contributed to the scientific community by editing special issues and reviewing for top-tier journals.

Research Interests 🔬

Biomaterials & Bioelectronics: Developing biodegradable LEDs for real-time monitoring of anticancer drugs.

Drug Delivery Systems: Improving the precision and safety of therapeutic treatments using liposomes, nanoparticles, and hydrogels.

Tissue Engineering: Engineering conducting scaffolds for neural tissue regeneration.

Molecular Interactions: Exploring the interaction between catechins and cellular membranes for their antioxidant effects.

Awards and Honors 🏆

Ana has been recognized for her exceptional contributions to bioelectronics and biomaterials. Some notable projects she has worked on include:

European Innovation Council, EIC PathFinder (2022-2025)

Co-PI for "Magnetic field-assisted MSCs-based therapies" (La Caixa Foundation, 2022)

Master Fellow in Pharmacokinetic Analysis of Nanostructured Films

Selected Publications 📚

Heparinized Acellular Hydrogels for Magnetically Induced Wound Healing Applications

Authors: Pires, F., Silva, J.C., Ferreira, F.C., Portugal, C.A.M.
Journal: ACS Applied Materials and Interfaces
Year: 2024, Volume: 16(8), Pages: 9908–9924
Citations: 4

Indium-gallium-zinc-oxide Based Semitransparent Electrodes on Flexible Substrates for Biodegradable Electronics

Authors: Pompilio, M., Gharehbagh, J.S., Krik, S., Ciocca, M., Cacialli, F.
Conference: 6th IEEE International Flexible Electronics Technology Conference, IFETC 2024 - Proceedings
Year: 2024

Magnetic-Responsive Liposomal Hydrogel Membranes for Controlled Release of Small Bioactive Molecules—An Insight into the Release Kinetics

Authors: Pereira, L., Ferreira, F.C., Pires, F., Portugal, C.A.M.
Journal: Membranes
Year: 2023, Volume: 13(7), Article: 674
Citations: 5

The Impact of Blue Light in Monolayers Representing Tumorigenic and Nontumorigenic Cell Membranes Containing Epigallocatechin-3-gallate

Authors: Pires, F., Magalhães-Mota, G., Geraldo, V.P.N., Oliveira, O.N., Raposo, M.
Journal: Colloids and Surfaces B: Biointerfaces
Year: 2020, Volume: 193, Article: 111129
Citations: 19

Effect of Epigallocatechin-3-gallate on DMPC Oxidation Revealed by Infrared Spectroscopy

Authors: Pires, F., Rodrigues, B., Magalhães-Mota, G., Ribeiro, P.A., Raposo, M.
Conference: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture)
Year: 2020

 

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link